KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 81 filers reported holding KEROS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,490,400 | -20.7% | 580,000 | 0.0% | 0.33% | -15.7% |
Q2 2023 | $23,304,400 | +81.9% | 580,000 | +93.3% | 0.39% | +67.7% |
Q1 2023 | $12,810,000 | -29.4% | 300,000 | -29.8% | 0.24% | -3.7% |
Q2 2021 | $18,152,000 | -31.0% | 427,414 | 0.0% | 0.24% | -37.4% |
Q1 2021 | $26,307,000 | +7.8% | 427,414 | +23.5% | 0.39% | +4.3% |
Q4 2020 | $24,407,000 | – | 346,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 321,300 | $12,087,000 | 4.99% |
First Light Asset Management, LLC | 598,213 | $22,505,000 | 2.28% |
Nantahala Capital Management | 845,692 | $31,815,000 | 2.06% |
CHI Advisors LLC | 200,229 | $7,533,000 | 2.03% |
Fairmount Funds Management LLC | 272,498 | $10,251,000 | 1.80% |
Altium Capital Management LP | 88,000 | $3,311,000 | 1.21% |
Orbimed Advisors | 1,679,417 | $63,180,000 | 1.17% |
SPHERA FUNDS MANAGEMENT LTD. | 206,819 | $7,781,000 | 1.08% |
Parkman Healthcare Partners LLC | 99,927 | $3,759,000 | 1.07% |
Soleus Capital Management, L.P. | 146,000 | $5,493,000 | 0.75% |